Immunohistochemistry of bone-marrow biopsy

Area of Science:

• Hematopathology
• Oncology
• Diagnostic Pathology

Background:

• Conventional morphologic evaluation of bone marrow needle biopsy (BMNB) is often insufficient for definitive diagnosis.
• Immunohistochemistry (IHC) provides an objective method to aid in BMNB interpretation.
• Accurate diagnosis of BMNB is critical for patient management and treatment.

Purpose of the Study:

• To highlight the essential role of immunohistochemistry in diagnosing challenging bone marrow needle biopsies.
• To detail the technical procedures enabling widespread IHC application in BMNB studies.
• To outline antibody panels required for identifying key pathological conditions in BMNB.

Main Methods:

• Extensive application of immunohistochemistry techniques to bone marrow needle biopsy samples.
• Development and utilization of specific antibody panels for diagnostic purposes.
• Morphologic evaluation of BMNB specimens.

Main Results:

• Immunohistochemistry provides an easy and objective key for interpreting BMNB patterns in a significant percentage of cases.
• Specific antibody panels facilitate the identification of the most relevant pathological conditions.
• Optimized technical procedures allow for the broad application of IHC in BMNB analysis.

Conclusions:

• Immunohistochemistry is indispensable for achieving a firm diagnosis in cases where BMNB morphology is inconclusive.
• The described technical procedures and antibody panels enhance the diagnostic utility of IHC in bone marrow pathology.
• This approach improves the accuracy and objectivity of BMNB interpretation, aiding in the diagnosis of critical conditions.